Disease | rheumatoid arthritis |
Symptom | C0024314|lymphoproliferative disorders |
Sentences | 2 |
PubMedID- 23269079 | Successful treatment of immunodeficiency-associated ebv-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration. |
PubMedID- 23560463 | Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, epstein-barr virus, and clonality are important predictors of disease progression and regression. |
Page: 1